Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:drug
|
| gptkbp:activeIngredient |
gptkb:nitazoxanide
|
| gptkbp:approvalYear |
2020
|
| gptkbp:ATCCode |
gptkb:P01AX11
|
| gptkbp:contraindication |
hypersensitivity to nitazoxanide
|
| gptkbp:FDAApproved |
yes
|
| gptkbp:form |
gptkb:tablet
|
| https://www.w3.org/2000/01/rdf-schema#label |
KIFTAB
|
| gptkbp:indicationAgeGroup |
children 1 year and older
|
| gptkbp:manufacturer |
gptkb:Lupin_Pharmaceuticals
|
| gptkbp:mechanismOfAction |
interferes with the pyruvate:ferredoxin oxidoreductase enzyme-dependent electron transfer reaction
|
| gptkbp:pregnancyCategory |
B (US)
|
| gptkbp:prescriptionStatus |
prescription only
|
| gptkbp:routeOfAdministration |
oral
|
| gptkbp:sideEffect |
nausea
vomiting abdominal pain headache |
| gptkbp:usedFor |
treatment of diarrhea caused by Giardia lamblia
treatment of diarrhea caused by Cryptosporidium parvum |
| gptkbp:bfsParent |
gptkb:Fanning_Island
|
| gptkbp:bfsLayer |
6
|